Apyx Medical Corporation APYX · Stock Open Apyx Medical Corporation in new tab
Apyx Medical Corporation Analysis (APYX)
Is Apyx Medical Corporation a good investment? Apyx Medical Corporation (APYX) is currently trading at 4.18 USD. Market analysts have a consensus price target of 6.60 USD. This suggests a potential upside from current levels.
Earnings Schedule: Apyx Medical Corporation is expected to release its next earnings report on Aug. 6, 2026. The market consensus estimate for Forward EPS is -0.25.
Investor FAQ
Does Apyx Medical Corporation pay a dividend?
No, it does not currently pay a dividend.
What asset class is Apyx Medical Corporation?
Apyx Medical Corporation is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 6, 2026. The company currently has a trailing EPS of -0.22.
Company Profile
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Community Discussion